4//SEC Filing
Branning Todd P. 4
Accession 0001723128-19-000127
CIK 0001723128other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:26 PM ET
Size
7.6 KB
Accession
0001723128-19-000127
Insider Transaction Report
Form 4
Branning Todd P.
SVP, Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option
2019-11-13−163,666→ 0 totalExercise: $12.44Exp: 2029-01-22→ Class A Common Stock (163,666 underlying) - Award
Stock Option
2019-11-13+163,666→ 163,666 totalExercise: $2.75Exp: 2029-01-22→ Class A Common Stock (163,666 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on January 22, 2019, and will vest in four equal annual installments beginning on January 22, 2020.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001765274
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:26 PM ET
- Size
- 7.6 KB